Working… Menu

Home Blood Pressure Monitoring Project (HBPM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01162759
Recruitment Status : Completed
First Posted : July 15, 2010
Last Update Posted : April 6, 2012
American Heart Association
Information provided by (Responsible Party):
Kaiser Permanente

Brief Summary:
The goal of this project is to improve hypertension control at Kaiser Permanente Colorado (KPCO) by implementing a population-based multi-factorial intervention that uses home BP monitors that can download BP readings to KPCO's health records via internet, interactive voice response (IVR) technology, and multidisciplinary care team. Participants will be randomized to either the home blood pressure monitoring group receiving the multi-factorial intervention or the usual care group who will be receiving Kaiser standard of care. We will determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines. The study hypothesis is that a higher proportion of patients with uncontrolled hypertension in the home blood pressure monitoring (HBPM) group will achieve their target blood pressure compared to those in the usual care (UC) group.

Condition or disease Intervention/treatment Phase
Hypertension Behavioral: Home Blood Pressure Monitoring Not Applicable

Detailed Description:



• To determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines


The following parameters will be evaluated between groups:

  • Change in BP measures between baseline and at 6 months
  • Proportion of patients who are receiving antihypertensive treatments in accordance to national clinical practice guidelines
  • Adherence to hypertensive medication regimen during the 6-month follow-up period
  • Patient satisfaction with the care model.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 348 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Home Blood Pressure Monitoring Program
Study Start Date : July 2008
Actual Primary Completion Date : July 2010
Actual Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
No Intervention: Usual Care
The control group receiving usual care
Experimental: Home Blood Pressure Monitoring Group
Intervention group
Behavioral: Home Blood Pressure Monitoring
Home blood pressure readings are taken at least 3 times a week, uploaded to a Microsoft Health Vault account through American Heart Association Heart360 at least 1 time per week. Patients are followed by a clinical pharmacist, with physician oversight, who will make adjustments to antihypertensive medications or suggest additional medications using national JNC VII and KPCO hypertension guidelines.
Other Name: HBPM

Primary Outcome Measures :
  1. BP at 6 months [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18 to 85 years At least 1 diagnosis for hypertension,

    • Receive primary care from one of the participating clinics,
    • The two most recent BPs documented within that last 24 months are elevated (SBP>140 and/or DBP>90)
    • Receiving < 3 antihypertensive medications, and
    • Have access to a computer with a USB port.

Exclusion Criteria:

  • Pregnant, or breast-feeding,
  • Patients on dialysis or being followed by nephrology,
  • Patients with coronary artery disease, given these patients are already followed by the Clinical Pharmacy Cardiac Risk Service (CPCRS),
  • On KPCO "Do Not Call" or deceased list,
  • PCP does not give permission to include patient in the study,
  • BP is at or below target at the baseline study visit,
  • Not English-speaking.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01162759

Layout table for location information
United States, Colorado
Kaiser Permanente Colorado, Institute of Health Research
Denver, Colorado, United States, 80231
Sponsors and Collaborators
Kaiser Permanente
American Heart Association
Layout table for investigator information
Principal Investigator: David J Magid, MD, MPH Kaiser Permanente
Principal Investigator: Kari Olson, PharmD Kaiser Permanente
Principal Investigator: Sarah J Billups, PharmD Kaiser Permanente
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Kaiser Permanente Identifier: NCT01162759    
Other Study ID Numbers: CO-08DMagi-01
First Posted: July 15, 2010    Key Record Dates
Last Update Posted: April 6, 2012
Last Verified: April 2012
Keywords provided by Kaiser Permanente:
hypertension, intervention
Additional relevant MeSH terms:
Layout table for MeSH terms
Vascular Diseases
Cardiovascular Diseases